Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0139590ea19b8f40bb1e617eda506ef9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_667df88c299c060787e51b7412c5a69f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64f3d17bd6135140122675227dd05a02 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-25 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
filingDate |
2009-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d67611c00e0fbd3a58b971018f413539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62015f26567955a326239b0993e020ba |
publicationDate |
2013-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8349899-B1 |
titleOfInvention |
Selective inhibitors of EG5 motors and methods of use |
abstract |
Embodiments of the present invention comprises a compound of formula I or its enantiomer, diastereomer, stereoisomer or its pharmaceutically acceptable salt, methods of use and methods of synthesis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017516790-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023145372-A1 |
priorityDate |
2008-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |